The UCLA School of Dentistry partnered with a South Korean semiconductor company to bring a saliva-based diagnostic technology into clinics – with the goal of enabling the noninvasive, early detection of diseases such as cancer. Read more...
Photo: The UCLA School of Dentistry will partner with Dongwoon Anatech to annually support EFIRM, an electrochemical platform that detects molecular targets such as cancer mutations in small samples of blood or saliva. (Courtesy of Ben Alkaly)






